Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 4Multiple Pulmonary Nodules 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solitary Pulmonary Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Recurrence 1Melanoma 1Lymphoma, Follicular 1Lung Diseases 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Glioma 1Depressive Disorder, Major 1Breast Neoplasms 1Breast Neoplasm Female 1Bone Neoplasms 1Barrett Esophagus 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

entinostat 3Carboplatin 3Pemetrexed 2Bronchoscopy 2sotorasib 1pralsetinib 1pembrolizumab 1osimertinib 1lorlatinib 1ficlatuzumab 1exemestane 1demcizumab 1cobimetinib 1camrelizumab 1aflibercept 1Tyrosine Kinase Inhibitors 1Thrombin 1Temozolomide 1TachoSil 1Saline Solution 1Radiomics 1Paclitaxel 1One-Lung Ventilation 1Nutritional Status 1Microscopy, Confocal 1Gefitinib 1Fibrinogen 1Exercise 1Erlotinib Hydrochloride 1Diagnostic Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lung Diseases × Diagnostic Imaging × Clear all
NCT03704870 2020-05-01

Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection

University Health Network, Toronto

Phase 2 Completed
50 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡